Effective destruction of Fas-deficient insulin-producing β cells in type 1 diabetes

被引:61
作者
Apostolou, I
Hao, ZY
Rajewsky, K
von Boehmer, H
机构
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Adv Med Discovery Inst, Toronto, ON M5G 2C1, Canada
[3] Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA
关键词
Fas receptor; diabetes; beta cell death; autoimmunity; conditional knockout;
D O I
10.1084/jem.20030698
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In type I diabetes, autoimmune T cells cause destruction of pancreatic beta cells by largely unknown mechanism. Previous analyses have shown that beta cell destruction is delayed but can occur in perforin-deficient nonobese diabetic (NOD) mice and that Fas-deficient NOD mice do not develop diabetes. However, because of possible pleiotropic functions of Fas, it was not clear whether the Fas receptor was an essential mediator of beta cell death in type 1 diabetes. To directly test this hypothesis, we have generated a beta cell-specific knockout of the Fas gene in a transgenic model of type I autoimmune diabetes in which CD4(+) T cells with a transgenic TCR specific for influenza hemagglutinin (HA) are causing diabetes in mice that express HA under control of the rat insulin promoter. Here we show that the Fas-deficient mice develop autoimmune diabetes with slightly accelerated kinetics indicating that Fas-dependent apoptosis of beta cells is a dispensable mode of cell death in this disease.
引用
收藏
页码:1103 / 1106
页数:4
相关论文
共 19 条
  • [1] Mechanisms of β cell death in diabetes:: A minor role for CD95
    Allison, J
    Strasser, A
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (23) : 13818 - 13822
  • [2] Perforin-independent β-cell destruction by diabetogenic CD8+ T lymphocytes in transgenic nonobese diabetic mice
    Amrani, A
    Verdaguer, J
    Anderson, B
    Utsugi, T
    Bou, S
    Santamaria, P
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (08) : 1201 - 1209
  • [3] The NOD mouse - Introduction
    Bach, JF
    Mathis, D
    [J]. RESEARCH IN IMMUNOLOGY, 1997, 148 (05): : 285 - 286
  • [4] The role of Fas in autoimmune diabetes
    Chervonsky, AV
    Wang, Y
    Wong, FS
    Visintin, I
    Flavell, RA
    Janeway, CA
    Matis, LA
    [J]. CELL, 1997, 89 (01) : 17 - 24
  • [5] ON THE VARIOUS MANIFESTATIONS OF SPONTANEOUS AUTOIMMUNE DIABETES IN RODENT MODELS
    DEGERMANN, S
    REILLY, C
    SCOTT, B
    OGATA, L
    VONBOEHMER, H
    LO, D
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (12) : 3155 - 3160
  • [6] Requirement of Fas for the development of autoimmune diabetes in nonobese diabetic mice
    Itoh, N
    Imagawa, A
    Hanafusa, T
    Waguri, M
    Yamamoto, K
    Iwahashi, H
    Moriwaki, M
    Nakajima, H
    Miyagawa, J
    Namba, M
    Makino, S
    Nagata, S
    Kono, N
    Matsuzawa, Y
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (04) : 613 - 618
  • [7] Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice
    Kagi, D
    Odermatt, B
    Seiler, P
    Zinkernagel, RM
    Mak, TW
    Hengartner, H
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (07) : 989 - 997
  • [8] T-HELPER CELL SUBSETS IN INSULIN-DEPENDENT DIABETES
    KATZ, JD
    BENOIST, C
    MATHIS, D
    [J]. SCIENCE, 1995, 268 (5214) : 1185 - 1188
  • [9] Kim YH, 1999, EUR J IMMUNOL, V29, P455, DOI 10.1002/(SICI)1521-4141(199902)29:02<455::AID-IMMU455>3.0.CO
  • [10] 2-A